Earnings History Data for Tango Therapeutics (TNGX) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Tango Therapeutics
Tango Therapeutics Inc. is a biotechnology company. It focused on discovering and delivering precision cancer medicines. Tango Therapeutics Inc., formerly known as BCTG Acquisition Corp., is based in CAMBRIDGE, Mass.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 06-11-2024 | PM | TNGX | Tango Therapeutics | 553.00 | -0.27 | -0.34 | 0.00 | Tango Therapeutics GAAP EPS of -$0.27 beats by $0.07, revenue of $11.6M beats by $3.53M [11/6/2024 10:07 AM] |
3.35 | -1.83 (-35.42%) |
3.15 | -2.03 (-39.21%) |
2.91 - 13.01 | 13,044,306 | 1,520,000 | 507,822 | ||
|
||||||||||||||||||
| 07-08-2024 | PM | TNGX | Tango Therapeutics | 943.00 | -0.24 | -0.34 | 0.00 | Tango Therapeutics GAAP EPS of -$0.24, revenue of $19.87M [8/7/2024 9:27 AM] |
8.78 | -0.23 (-2.55%) |
9.65 | 0.64 (7.10%) |
3.36 - 13.03 | 709,906 | 620,000 | 9,905 | ||
| 08-05-2024 | PM | TNGX | Tango Therapeutics | 842.00 | -0.35 | -0.31 | 0.00 | Tango Therapeutics Q1 GAAP EPS of -$0.35 misses by $0.04 [5/8/2024 9:52 AM] |
7.91 | 0.06 (0.76%) |
7.91 | 0.0 (0.00%) |
2.47 - 13.03 | 656,116 | 480,000 | 3,014 | ||
| 18-03-2024 | PM | TNGX | Tango Therapeutics | 927.00 | -0.32 | -0.28 | 0.00 | Tango Therapeutics GAAP EPS of -$0.32 misses by $0.04, revenue of $5.43M misses by $2.81M [3/18/2024 7:11 AM] |
8.40 | -0.63 (-6.98%) |
8.67 | -0.36 (-3.99%) |
2.47 - 13.03 | 880,588 | 890,000 | 1,156 | ||
| 08-11-2023 | PM | TNGX | Tango Therapeutics | 854.00 | -0.23 | -0.34 | 0.00 | Tango Therapeutics GAAP EPS of -$0.23, revenue of $10.7M [11/8/2023 8:44 AM] |
8.94 | 0.33 (3.83%) |
8.94 | 0.0 (0.00%) |
2.47 - 13.03 | 1,094,964 | 640,000 | 11,205 | ||
| 07-08-2023 | PM | TNGX | Tango Therapeutics | 300.00 | -0.23 | -0.35 | 0.00 | Tango Therapeutics GAAP EPS of -$0.23 beats by $0.08, revenue of $14.6M beats by $7.65M [8/7/2023 7:19 AM] |
3.44 | 0.04 (1.18%) |
3.41 | 0.01 (0.29%) |
2.47 - 8.56 | 151,147 | 100,000 | 7,193 | ||
| 09-05-2023 | PM | 7:00 AM ET (May 9) |
TNGX | Tango Therapeutics | 303.00 | -0.32 | -0.36 | 0.00 | Tango Therapeutics GAAP EPS of -$0.32 beats by $0.03, revenue of $5.77M misses by $1M [5/9/2023 8:54 AM] |
3.66 | 0.22 (6.40%) |
3.50 | 0.06 (1.74%) |
3.10 - 8.56 | 373,999 | 140,000 | 1,005 | |
| 10-11-2022 | PM | TNGX | Tango Therapeutics | 681.00 | -0.33 | -0.32 | 0.00 | Tango Therapeutics GAAP EPS of -$0.33 misses by $0.01, revenue of $6.92M beats by $1.28M [11/10/2022 9:23 AM] |
7.18 | -0.41 (-5.40%) |
7.59 | 0.0 (0.00%) |
3.18 - 14.31 | 188,820 | 220,000 | 2,335 | ||
| 11-05-2022 | PM | TNGX | Tango Therapeutics | 468.00 | -0.29 | -0.28 | 0.00 | Tango Therapeutics GAAP EPS of -$0.29 misses by $0.01, revenue of $5.76M misses by $0.07M [5/11/2022 7:42 AM] |
4.65 | -0.37 (-7.37%) |
0.0 | 0.0 (0.00%) |
4.59 - 18.84 | 305,998 | 210,000 | 0 | ||
| 28-03-2022 | PM | TNGX | Tango Therapeutics | 626.00 | -0.25 | -0.28 | 0.00 | Tango Therapeutics GAAP EPS of -$0.25 in-line, revenue of $5.72M misses by $1.01M [3/28/2022 8:16 AM] |
7.03 | 0.02 (0.29%) |
7.03 | 0.0 (0.00%) |
6.86 - 18.84 | 372,011 | 560,000 | 895 | ||